Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40013113
Localisation
France
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
24/07/2025
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2045
Overall Net-Zero Target: Ipsen commits to reach net-zero greenhouse gas emissions across the value chain by 2045. Near-Term Targets: Ipsen commits to reduce absolute scope 1 and 2 GHG emissions 57% by 2030 from a 2019 base year. Ipsen also commits to reduce absolute scope 3 GHG emissions 28% within the same timeframe. Long-Term Targets: Ipsen commits to reduce absolute scopes 1, 2 and 3 GHG emissions 90% by 2045 from a 2019 base year.
Statut
Targets setAnnée cible
2045
Statut
BA1.5 memberDate d'engagement
30/09/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
FR0010259150
LEI
549300M6SGDPB4Z94P11
Expired commitment
Source : Science Based Targets initiative | Données publiques